Back To Search Instructions
10 protocols meet the specified criteria
Disease Site: Other Female Genital
Protocol No.TitleStatus
1200000556Can diet and physical activity modulate ovarian, fallopian tube and primary peritoneal cancer progression-free survival? (GOG-0225) (LIVES)Open
1300000755A Randomized Phase II Evaluation of Carboplatin/Paclitaxel with and without Trastuzumab (Herceptin) in HER2/neu+ Patients with Advanced/Recurrent Uterine Serous Papillary Carcinoma (Yale-USPC) Phase 2 / Carbo+taxel +/- Trastuzumab / HER2/neu+, Uterine Serous Papillary Carcinoma (Yale-USPC) Closed
1412595351A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NCS#91485) Verses Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stave IVB, or Recurrent Enometrial Cancer (GOG286b)Closed
1606636273A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal CancerOpen
PHXA-15-0002-10-15Can Diet and Physical Activity Modulate Ovarian Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?Open
PHXA-15-0003-10-15GROningen INternational Study on Sentinel nodes in Vulvar cancer GROINSS-V) Closed
PHXA-15-0028-80-15A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerClosed
PHXB-17-0013-71-16Dosimetric comparison for IMRT, VMAT, SBRT/SRS, & Brachytherapy for extracranial sitesOpen
PHXE-17-0216-10-15EAY131: Molecular Analysis for Therapy Choice (MATCH) Open
PHXE-17-0349-10-15DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare TumorsOpen